Tumour necrosis factor in man: Clinical and biological observations
Peter J. Selby(Centre for Addiction and Mental Health), J HUMPHREYS, TJ McElwain, Stuart Hobbs(Royal Marsden NHS Foundation Trust), Alison Jones(Roche (Switzerland)), Kenneth C.H. Fearon, A. Hilary Calvert(Newcastle University), Emily B. Jackson(Royal Marsden NHS Foundation Trust), David R. Newell(Newcastle University), C. Viner
Cited by 203
Related Papers
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
|Journal of Clinical Oncology|2009|850
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
|BMC Cancer|2010|755
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2002|430
Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching Hospitals
|Journal of Clinical Oncology|2005|278